Scaling of the Granulation Process in the Conditions of GMP Training Center and Assessment of Possible Risks
https://doi.org/10.33380/2305-2066-2021-10-3-131-137
Abstract
Introduction. The stage of wet granulation is often used in the technology of solids. The method of wet granulation in a mixer-granulator with high shear force can be regarded as the most complicated method of its implementation from the engineering and technological point of view. The mixer-granulator has two mixers located in mutually perpendicular planes. Using an impeller, dry components are mixed, and the chopper, turning on when spraying a humidifier, ensures the formation of granules. By setting different chopper rotational speed, granules of different sizes can be obtained. This granulator has the following advantages: it provides a high product yield (≥ 99 %), takes up small workspaces, and the closed design ensures environmental protection.
Aim. The aim of the research is to scale the granulation process, on the example of the solids production technology, using the wet granulation stage - in a mixer-granulator with high shear force.
Materials and methods. Dry extract «N» and auxiliary substances were used as a pharmaceutical substance: lactose monohydrate, microcrystalline cellulose (MCC) (MICROCEL® MC-102), potato starch, povidone (Plasdone™ K-29/32), calcium stearate. Granulate under scaling conditions was produced in a mixer-granulator with high shear force. Technological properties of dry extract «N» and granulate were determined by the methods described in National pharmacopeia XIV.
Results and discussion. On the basis of experimental studies, it was found that the resulting granulate, both when obtained under laboratory conditions and under scaling conditions, has good flowability, and also has a homogeneous fractional composition. The presence of a grinder in the mixer-granulator made it possible to obtain a more uniform fractional composition of the granulate. A 10-fold increase in loading did not affect the composition of the granulate. When scaling the pelletizing process, a risk analysis was carried out, factors influencing the technological process were identified and structured. It turned out that the most important stages are mixing and the actual granulation. To obtain a homogeneous mixture, additional equipment was used - a mixer.
Conclusion. As a result of scaling up the granulation process, the parameters of wet granulation in the mixer-granulator (optimal loading, impeller and grinder rotation frequency), technological properties of the resulting granulate, and risks affecting the technological process were selected. were evaluated and a causal diagram (Ishikawa diagram) was drawn.
About the Authors
O. N. AbrosimovaRussian Federation
Olesya N. Abrosimova.
14A, Prof. Popov str., Saint-Petersburg, 197376.
M. A. Burakova
Russian Federation
Marina A. Burakova.
14A, Prof. Popov str., Saint-Petersburg, 197376.
References
1. Mogilyuk V. Smesiteli-granulyatory s vysokim usiliem sdviga v proizvodstve tverdykh lekarstvennykh form, razrabotke i masshtabirovanii. [High shear mixer granulators in solid dosage formulation, design and scale-up]. Farmatsevticheskaya otrasl' = Pharmaceutical industry. 2015;2(49):30-35. (In Russ.)
2. Reztsov E., Mogilyuk V. Ryabko D. Transfer tekhnologiy v farmatsevticheskoy otrasli [Technology transfer in the pharmaceutical industry]. Farmatsevticheskaya otrasl' = Pharmaceutical industry. 2010;2(19):49-52. (In Russ.)
3. Rudko A. I., Konikov D. L., Sidorov K. O., Ilyinova Ju. G. Stake on transfer: evolution of a regulatory framework for the development of the pharmaceutical industry. Farmatsiya = Pharmacy, 2020;69(7):5-9. (In Russ.) DOI: 10.29296/25419218-2020-07-01.
4. Beregovykh V. V., Spitskiy O. R. Technology Transfer to the Facility for Production of Medicines. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk = Annals of the Russian Academy of Medical Sciences. 2013; 68(12):49-57. (In Russ.).
5. Vlasenko Yu. V. Project-oriented approach to finished pharma product development in the context of generic polycomponent drug containing amoxycillin and clavulanic acid. Razrabotka i registratsiya lekarstvennykh sredstv = Drug development & registration. 2016;(1):30-36. (In Russ.)
6. Diomina N. B. Pharmaceutical development: review of equipment for laboratory development and pilot batches production of solid dosage forms. Razrabotka i registratsiya lekarstvennykh sredstv = Drug development & registration. 2016;(1):38-46. (In Russ.)
7. Filippova N. I., Vainshtein V. A., Gretskov P. S. Formulation and technology influence on release rate of drug from tablets in case of paracetamol. Aktual'nye problemy meditsiny = Challenges in modern medicine. 2018;41(1):133-144. (In Russ.) DOI: 10.18413/2075-4728-2018-41-1-133-144.
8. Shanmugam S. Granulation techniques and teqnologies: recent progresses. Biolpacts. 2015;5(1):55-63. DOI: 10.15171/bi.2015.04.
9. Blynskaya E. V., Yudina D. V., Alekseyev K. V., Alekseyev V. K., Minaev S. V. Comparative compressibility study of tablet GML-1 mixtures obtained by wet granulation technology. Volgogradskiy nauchno-meditsinskiy zhurnal = Volgograd Journal of Medical Scientific Research. 2019;3:49-54. (In Russ.)
10. Gosudarstvennaya farmakopeya Rossiyskoy Federatsii. XIV izdanie [The State Pharmacopoeia of the Russian Federation. XIV edition]. Moscow: Ministerstvo zdravookhraneniya Rossiyskoy Federatsii. 2018. Available at: http://femb.ru/femb/pharmacopea.php. Accessed: 25.05.2021. (In Russ.)
11. Novikova E.K., Chachin D.A., Kaukhova I.E., Minina S.A. Development and standardization of granules in hard gelatin capsules based on the composition of dry extracts of Bidens Tripartita, Solidago Canadensis L. and Agrimonia Eupatoria herbs. Razrabotka i registratsiya lekarstvennykh sredstv = Drug development & registration. 2018;(4):44-48. (In Russ.)
12. Egoshina Yu. A., Potselueva L. A. Modern tablet excipients. Uspekhi sovremennogo estestvoznaniya. 2009;1 0:30-33. (In Russ.)
Supplementary files
|
1. Графический абстракт | |
Subject | ||
Type | Исследовательские инструменты | |
View
(1MB)
|
Indexing metadata ▾ |
Review
For citations:
Abrosimova O.N., Burakova M.A. Scaling of the Granulation Process in the Conditions of GMP Training Center and Assessment of Possible Risks. Drug development & registration. 2021;10(3):131-137. (In Russ.) https://doi.org/10.33380/2305-2066-2021-10-3-131-137